Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study-Reference-Cited by-同舟云学术

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Published:2018-08 Issue:8 Volume:19 Page:1094-1106
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Kim Stefano,François Eric,André Thierry,Samalin Emmanuelle,Jary Marine,El Hajbi Farid,Baba-Hamed Nabil,Pernot Simon,Kaminsky Marie-Christine,Bouché Olivier,Desrame Jérôme,Zoubir Mustapha,Ghiringhelli François,Parzy Aurélie,De La Fouchardiere Christelle,Smith Denis,Deberne Mélanie,Spehner Laurie,Badet Nicolas,Adotevi Olivier,Anota Amélie,Meurisse Aurélia,Vernerey Dewi,Taieb Julien,Vendrely Véronique,Buecher Bruno,Borg Christophe

Publisher

Elsevier BV

Subject

Oncology

Reference35 articles.

1. Cancer statistics, 2018;Siegel;CA Cancer J Clin,2018

2. International trends in anal cancer incidence rates;Islami;Int J Epidemiol,2016

3. Anal cancer treatment: current status and future perspectives;Ghosn;World J Gastroenterol,2015

4. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research;Lancet,1996

5. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up;Glynne-Jones;Radiother Oncol,2014

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anal carcinoma - exploring the epidemiology, risk factors, pathophysiology, diagnosis, and treatment;World Journal of Experimental Medicine;2024-09-20

2. Management of Metastatic Anal Cancer;Surgical Oncology Clinics of North America;2024-09

3. Recent developments in immunotherapy for gastrointestinal tract cancers;Journal of Hematology & Oncology;2024-08-09

4. Immunological Checkpoint Blockade in Anal Squamous Cell Carcinoma: Dramatic Responses Tempered By Frequent Resistance;Current Oncology Reports;2024-06-11

5. Atezolizumab plus modified docetaxel, cisplatin, and fluorouracil as first-line treatment for advanced anal cancer (SCARCE C17-02 PRODIGE 60): a randomised, non-comparative, phase 2 study;The Lancet Oncology;2024-04